...
首页> 外文期刊>Procedia Manufacturing >Micro Computed Tomography Detects Changes in Liver Density in Control and in Prediabetes Rats
【24h】

Micro Computed Tomography Detects Changes in Liver Density in Control and in Prediabetes Rats

机译:微型计算机断层扫描技术可检测对照组和糖尿病前期大鼠肝脏密度的变化

获取原文

摘要

Fatty liver disease is an early event in the development of insulin resistance that predicts the presence and progression of the metabolic syndrome. In humans, fatty liver diagnosis is usually performed by imaging techniques based on ultrasound, computed tomography and magnetic resonance. Rodent models are often used in metabolic research allowing access to tissue biopsies however, studies describing ex vivo computed tomography of biological samples are scarce. X-ray Micro Computed Tomography (Micro-CT) is an imaging technique that reveals the internal structure of materials in great detail, also allowing a quantitative analysis of properties such as density measured as arbitrary Hounsfield Units (HU). Herein, we tested the hypothesis that Micro-CT detects changes in liver tomographic density induced by metabolic diseases and its reversal upon therapeutic surgical intervention. Two groups of male Wistar rats were used: a group submitted to a hypercaloric diet for 14 weeks to induce prediabetes and the control group submitted to a standard diet). The animals were randomly submitted to a surgical treatment and maintained on their respective diets after the procedure for 11 more weeks. Liver and adipose tissues samples were excised and samples were scanned using a compact X-ray micro-CT scanner. The projection images obtained were analyzed and reconstructed and values of HU density were calculated after calibration for all samples. Results showed that liver density was lower in prediabetes rats (74.8±5.87 HU) than in control animals (97.2±6.3 HU), p<0.05. Liver density was not affected by surgical treatment in control animals however, in prediabetes animals, the surgical therapy restored liver density to control values. Visceral fat density was significantly lower than hepatic density, as expected and was affected, neither by the disease condition nor by the surgical treatment. We concluded that micro-CT detects metabolic disease-induced changes in liver density, but not in visceral adipose tissue density in biopsy samples ex vivo. Changes in hepatic density, assessed by micro-CT, correlate with disease state and with therapeutic interventions.
机译:脂肪肝疾病是胰岛素抵抗发展中的早期事件,可预测代谢综合征的存在和发展。在人类中,脂肪肝的诊断通常通过基于超声,计算机断层扫描和磁共振的成像技术来进行。在代谢研究中经常使用啮齿动物模型,从而可以进行组织活检,但是,很少有描述生物样品的体外计算机断层扫描的研究。 X射线微计算机断层扫描(Micro-CT)是一种成像技术,可以非常详细地揭示材料的内部结构,还可以定量分析诸如以任意Hounsfield单位(HU)测得的密度等性质。本文中,我们检验了以下假设:Micro-CT检测由代谢性疾病引起的肝脏断层扫描密度变化及其在治疗性手术干预下的逆转。使用了两组雄性Wistar大鼠:一组接受高热量饮食以诱导糖尿病前14周,而对照组接受标准饮食。手术后将动物随机接受手术治疗并保持其各自的饮食11周。切除肝脏和脂肪组织样品,并使用紧凑型X射线微CT扫描仪扫描样品。分析并重建获得的投影图像,并在校准所有样品后计算HU密度值。结果表明,糖尿病前期大鼠(74.8±5.87 HU)的肝脏密度低于对照组动物(97.2±6.3 HU),p <0.05。在对照动物中,肝脏密度不受手术治疗的影响,但是,在糖尿病前期动物中,手术治疗使肝脏密度恢复至对照值。如所预期的,内脏脂肪密度显着低于肝密度,并且不受疾病状况或外科治疗的影响。我们得出的结论是,微CT可以检测到代谢疾病引起的肝脏密度变化,但在活检样本中未检测到内脏脂肪组织密度变化。通过微CT评估的肝密度变化与疾病状态和治疗干预相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号